Driving Simulation

We partnered with CRC to establish lack of driving impairment after nighttime dosing of flibanserin in premenopausal women. The study, sponsored by Sprout Pharmaceuticals, was described as “reassuring” by the FDA.

Accurate driving performance data comparable in sensitivity to over-the-road testing, with:

• Faster study startup
• Lower cost
• No risk of property damage
• No risk of injuries

The CRC driving simulator has proven sensitivity to the effects of:

• Age
• Trauma
• Neurological disease
• Drowsiness
• CNS depressants
• CNS stimulants